Analyst Ratings for Progenics Pharmaceuticals (pgnx)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/30/2019 | Brookline Capital Markets | Kumaraguru Raja | New Coverage | Buy (N/A) |
10.00 (N/A) |
5.18 (4.10) |
-20.85% | Details |
| 12/7/2018 | Credit Suisse | N/A | New Coverage | Outperform (N/A) |
6.50 (N/A) |
4.64 (4.10) |
-11.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
